National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011
A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron em...
Gespeichert in:
| Veröffentlicht in: | Radiation protection dosimetry 2012-12, Vol.152 (4), p.334-338 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 338 |
|---|---|
| container_issue | 4 |
| container_start_page | 334 |
| container_title | Radiation protection dosimetry |
| container_volume | 152 |
| creator | Etard, Cécile Celier, David Roch, Patrice Aubert, Bernard |
| description | A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv. |
| doi_str_mv | 10.1093/rpd/ncs066 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02920221v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1239060564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-543878518b44c141ef45707c8c481ec64dabb3c478711072273c78383447dc83</originalsourceid><addsrcrecordid>eNo9kMFPwjAUhxujEUQv_gGmRzWZ9rVvazkSFDQh6oGTl6brujizrdgCyn_vEOT0e3n58h0-Qi6B3QEbivuwKO5bG1mWHZE-SOSJQJYdkz4DxEQhZz1yFuMnY1wOUzwlPc5TlUGa9cn7i1lWvjU1jauwdhvqS7roXq5d0sJHF2kZfEO_P3ztktwXGzp5mNK3x3kynlP3Y5qq_RNEWrV0Ekxr3fbiDOCcnJSmju5ivwMynzzOx0_J7HX6PB7NEiuUXCYpdqNSUDmiBQRXYiqZtMqiAmczLEyeC4tSSQAmOZfCSiWUQJSFVWJAbnbaD1PrRagaEzbam0o_jWZ6-2N8yBnnsIaOvd6xi-C_Vi4udVNF6-ratM6vogYuhixjaYYdertDbfAxBlce3MD0Nrvusutd9g6-2ntXeeOKA_rfWfwCbR96pQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1239060564</pqid></control><display><type>article</type><title>National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Etard, Cécile ; Celier, David ; Roch, Patrice ; Aubert, Bernard</creator><creatorcontrib>Etard, Cécile ; Celier, David ; Roch, Patrice ; Aubert, Bernard</creatorcontrib><description>A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv.</description><identifier>ISSN: 0144-8420</identifier><identifier>EISSN: 1742-3406</identifier><identifier>DOI: 10.1093/rpd/ncs066</identifier><identifier>PMID: 22586156</identifier><language>eng</language><publisher>England: Oxford University Press (OUP)</publisher><subject>Body Burden ; Data Collection ; Female ; Fluorodeoxyglucose F18 - analysis ; France - epidemiology ; Humans ; Life Sciences ; Male ; Multimodal Imaging - utilization ; Positron-Emission Tomography ; Radiation Dosage ; Radiopharmaceuticals - analysis ; Tomography, X-Ray Computed ; Whole Body Imaging - utilization ; Whole-Body Counting - statistics & numerical data</subject><ispartof>Radiation protection dosimetry, 2012-12, Vol.152 (4), p.334-338</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-543878518b44c141ef45707c8c481ec64dabb3c478711072273c78383447dc83</citedby><cites>FETCH-LOGICAL-c387t-543878518b44c141ef45707c8c481ec64dabb3c478711072273c78383447dc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22586156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02920221$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Etard, Cécile</creatorcontrib><creatorcontrib>Celier, David</creatorcontrib><creatorcontrib>Roch, Patrice</creatorcontrib><creatorcontrib>Aubert, Bernard</creatorcontrib><title>National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011</title><title>Radiation protection dosimetry</title><addtitle>Radiat Prot Dosimetry</addtitle><description>A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv.</description><subject>Body Burden</subject><subject>Data Collection</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18 - analysis</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Multimodal Imaging - utilization</subject><subject>Positron-Emission Tomography</subject><subject>Radiation Dosage</subject><subject>Radiopharmaceuticals - analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Whole Body Imaging - utilization</subject><subject>Whole-Body Counting - statistics & numerical data</subject><issn>0144-8420</issn><issn>1742-3406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMFPwjAUhxujEUQv_gGmRzWZ9rVvazkSFDQh6oGTl6brujizrdgCyn_vEOT0e3n58h0-Qi6B3QEbivuwKO5bG1mWHZE-SOSJQJYdkz4DxEQhZz1yFuMnY1wOUzwlPc5TlUGa9cn7i1lWvjU1jauwdhvqS7roXq5d0sJHF2kZfEO_P3ztktwXGzp5mNK3x3kynlP3Y5qq_RNEWrV0Ekxr3fbiDOCcnJSmju5ivwMynzzOx0_J7HX6PB7NEiuUXCYpdqNSUDmiBQRXYiqZtMqiAmczLEyeC4tSSQAmOZfCSiWUQJSFVWJAbnbaD1PrRagaEzbam0o_jWZ6-2N8yBnnsIaOvd6xi-C_Vi4udVNF6-ratM6vogYuhixjaYYdertDbfAxBlce3MD0Nrvusutd9g6-2ntXeeOKA_rfWfwCbR96pQ</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Etard, Cécile</creator><creator>Celier, David</creator><creator>Roch, Patrice</creator><creator>Aubert, Bernard</creator><general>Oxford University Press (OUP)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20121201</creationdate><title>National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011</title><author>Etard, Cécile ; Celier, David ; Roch, Patrice ; Aubert, Bernard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-543878518b44c141ef45707c8c481ec64dabb3c478711072273c78383447dc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Body Burden</topic><topic>Data Collection</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18 - analysis</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Multimodal Imaging - utilization</topic><topic>Positron-Emission Tomography</topic><topic>Radiation Dosage</topic><topic>Radiopharmaceuticals - analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Whole Body Imaging - utilization</topic><topic>Whole-Body Counting - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Etard, Cécile</creatorcontrib><creatorcontrib>Celier, David</creatorcontrib><creatorcontrib>Roch, Patrice</creatorcontrib><creatorcontrib>Aubert, Bernard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Radiation protection dosimetry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Etard, Cécile</au><au>Celier, David</au><au>Roch, Patrice</au><au>Aubert, Bernard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011</atitle><jtitle>Radiation protection dosimetry</jtitle><addtitle>Radiat Prot Dosimetry</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>152</volume><issue>4</issue><spage>334</spage><epage>338</epage><pages>334-338</pages><issn>0144-8420</issn><eissn>1742-3406</eissn><abstract>A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv.</abstract><cop>England</cop><pub>Oxford University Press (OUP)</pub><pmid>22586156</pmid><doi>10.1093/rpd/ncs066</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0144-8420 |
| ispartof | Radiation protection dosimetry, 2012-12, Vol.152 (4), p.334-338 |
| issn | 0144-8420 1742-3406 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_02920221v1 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
| subjects | Body Burden Data Collection Female Fluorodeoxyglucose F18 - analysis France - epidemiology Humans Life Sciences Male Multimodal Imaging - utilization Positron-Emission Tomography Radiation Dosage Radiopharmaceuticals - analysis Tomography, X-Ray Computed Whole Body Imaging - utilization Whole-Body Counting - statistics & numerical data |
| title | National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A57%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=National%20survey%20of%20patient%20doses%20from%20whole-body%20FDG%20PET-CT%20examinations%20in%20France%20in%202011&rft.jtitle=Radiation%20protection%20dosimetry&rft.au=Etard,%20C%C3%A9cile&rft.date=2012-12-01&rft.volume=152&rft.issue=4&rft.spage=334&rft.epage=338&rft.pages=334-338&rft.issn=0144-8420&rft.eissn=1742-3406&rft_id=info:doi/10.1093/rpd/ncs066&rft_dat=%3Cproquest_hal_p%3E1239060564%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1239060564&rft_id=info:pmid/22586156&rfr_iscdi=true |